Skip to main content

Table 3 Univariate analysis of clinical characteristics of asthmatic children associated with neuropsychiatric comorbidities (n, %)

From: Evaluation of neuropsychiatric comorbidities and their clinical characteristics in Chinese children with asthma using the MINI kid tool

Variables

Category

AWNC

(n = 69)

AONC

(n = 192)

χ2

P

Onset of asthma

≤3 years

44(63.8)

105(54.7)

1.709

0.191

>3 years

25(36.2)

87(45.3)

Severity of asthma

Severe persistent

13(18.8)

13(6.8)

8.244

0.004

Mild persistent

56(81.2)

179(93.2)

Asthma control level

Poor control

40(58.0)

71(37.0)

9.151

0.002

Good control

29(42.0)

121(63.0)

Anti-asthmatic drug usage

ICS

16(23.2)

15(7.8)

10.04

0.001

LTRA

4(5.8)

18(9.4)

0.471

0.493

LTRA+ICS

10(14.5)

45(23.4)

1.933

0.164

BA+ICS

6(8.7)

17(8.9)

0.043

0.835

BA+ICS + LTRA

33(47.8)

97(50.5)

0.003

0.958

Anti-asthmatic therapy

Monotherapy

20(29.0)

33(17.2)

4.366

0.037

Multidrug therapy

49(71.0)

159(82.8)

  

Regular follow-up

Yes

40(58.0)

105(54.7)

0.222

0.638

No

29(42.0)

87(45.3)

Family history

Yes

18(26.1)

43(22.4)

0.386

0.534

No

51(73.9)

149(77.6)

Asthma attacks

≥1 time monthly

8(11.6)

20(10.4)

7.034

0.071

≥ every 3 months, < 1 time monthly

32(46.4)

60(31.2)

≥ every 6 months, < 1 time every 3 months

16(23.2)

75(39.1)

No attack ≥1 year

13(18.8)

37(19.3)

Duration

> 3 years

50(72.5)

90(46.9)

13.365

0.000

≤3 years

19(27.5)

102(53.1)

  1. AWNC Asthma with neuropsychiatric comorbidities, AONC Asthma without neuropsychiatric comorbidities, ICS Inhaled corticosteroid, LTRA Leukotriene receptor agonists, BA Beta-2-agonists